Read the notice beyond the ingredient name
Find the original announcement through the pharmacy or FDA’s drug recall resources. Look for the product description, strength or formulation, affected lots, distribution details, and the requested action. A screenshot shared online may omit the part explaining which supplies are affected.
Do not assume every product containing sermorelin is included merely because one appears in a recall. Equally, do not assume a different clinic brand excludes you if both clinics use the same pharmacy. The dispenser and batch details are more useful than the subscription name. This guide describes how to respond to a notice; it does not announce a current sermorelin recall. Check the announcement date as well. An old notice can remain searchable long after its affected supply was distributed, while a new update can expand the original scope. Read any linked correction or update before concluding that the first version you found is the complete instruction.
Match the label and ask about missing identifiers
FDA advises comparing your medicine’s lot number with the recall notification. Photograph the full label and retain the packaging. If the identifier is absent, unreadable, or different from the format in the notice, contact the dispensing pharmacy with the prescription number and fill date.
A prescription number identifies your dispensing record; it may not be the same as a production lot. Do not decide the product is unaffected simply because those numbers differ. Ask the pharmacy to trace the supply it dispensed and give you a specific answer. If several vials came together, check each one rather than assuming the first label represents the entire shipment.
Follow the stated action and get clinical advice
Read whether the notice tells patients to stop using the affected product, contact a clinician, return it, or take another step. FDA explains that recall circumstances and actions vary. Avoid applying a blanket rule from a different medicine or recall. Contact your prescriber promptly to discuss what the notice means for your care.
If the instructions are unclear, tell the pharmacy exactly which product you have and ask it to resolve the uncertainty before further use. Do not substitute another person’s supply, change the prescription yourself, or use a product the notice says to stop. New serious symptoms require prompt medical assessment, not a wait for a customer-service investigation or a refund response.
Keep the product traceable while arranging resolution
Ask how the pharmacy wants affected supplies secured, returned, or disposed of. Retain the label information and correspondence even if the medication must be returned. Do not mail an injectable product or loose sharps using improvised packaging; obtain the relevant return instructions.
Keep the clinical and commercial questions separate. The prescriber advises on treatment interruption or alternatives. The pharmacy helps identify the affected supply and its disposition. The seller may handle credits, replacements, or subscriptions. Write down which organization accepted each responsibility and when you should expect the next response. This avoids a situation in which everyone assumes another party is managing the problem.
Close the loop on symptoms and replacement supply
Tell the clinician whether you used the affected product and whether you noticed any symptoms, including when they occurred. Exposure does not establish that a symptom was caused by the recalled medicine, and feeling well does not answer whether the product is affected. Both observations belong in an accurate account.
When a replacement arrives, verify its label and instructions rather than assuming the original directions still apply. If there is a suspected quality problem or adverse event, FDA’s product reporting guidance provides a separate route for sharing information. Keep the final recall resolution with your medication records so future clinicians can understand what happened and which supply was involved.